Bibliography
Found 1052 results
The Longitudinal Effects of Blood Pressure and Hypertension on Neurocognitive Performance in People Living with HIV. J Acquir Immune Defic Syndr. 2021 .
. Multimorbidity networks associated with frailty among middle aged and older people with HIV. AIDS. 2021 .
. Neurocognitive status and risk of mortality among people living with human immunodeficiency virus: an 18-year retrospective cohort study. Sci Rep. 2021 ;11(1):3738.
. Physical and Mental Health Screening in a New York City HIV Cohort During the COVID-19 Pandemic: A Preliminary Report. J Acquir Immune Defic Syndr. 2021 ;86(3):e54-e60.
. . Antiretroviral Penetration and Drug Transporter Concentrations in the Spleens of Three Preclinical Animal Models and Humans. Antimicrob Agents Chemother. 2020 ;64(10).
Assessing Cognitive Functioning in People Living With HIV (PLWH): Factor Analytic Results From CHARTER and NNTC Cohorts. J Acquir Immune Defic Syndr. 2020 ;83(3):251-259.
. Beta amyloid levels in cerebrospinal fluid of HIV-infected people vary by exposure to antiretroviral therapy. AIDS. 2020 ;34(7):1001-1007.
. Cannabis Exposure is Associated With a Lower Likelihood of Neurocognitive Impairment in People Living With HIV. J Acquir Immune Defic Syndr. 2020 ;83(1):56-64.
. Characteristics of Motor Dysfunction in Longstanding Human Immunodeficiency Virus. Clin Infect Dis [Internet]. 2020 ;71(6):1532-1538. Available from: https://pubmed.ncbi.nlm.nih.gov/31587032/
Circulating levels of ATP is a biomarker of HIV cognitive impairment. EBioMedicine. 2020 ;51:102503.
. Coronaviruses and the central nervous system. J Neurovirol. 2020 ;26(4):459-473.
. Correction to: A candidate gene study of intermediate histopathological phenotypes in HIV-associated neurocognitive disorders. J Neurovirol. 2020 ;26(4):509-510.
. The Effects of Low-Risk Drinking on Neurocognition Among Older Persons Living With HIV as Compared to Those Without HIV. Alcohol Clin Exp Res. 2020 ;44(7):1389-1399.
. Efficacy and safety of two-drug regimens for treatment of HIV in the central nervous system. AIDS. 2020 ;34(13):1975-1977.
. GluT4: A central player in hippocampal memory and brain insulin resistance. Exp Neurol. 2020 ;323:113076.
. Harnessing regulatory T cell neuroprotective activities for treatment of neurodegenerative disorders. Mol Neurodegener. 2020 ;15(1):32.
. Hepatitis C Virus Cure in Human Immunodeficiency Virus Coinfection Dampens Inflammation and Improves Cognition Through Multiple Mechanisms. J Infect Dis. 2020 ;222(3):396-406.
. HIV-1 Tat-mediated astrocytic amyloidosis involves the HIF-1α/lncRNA BACE1-AS axis. PLoS Biol. 2020 ;18(5):e3000660.
. Iron-regulatory genes are associated with Neuroimaging measures in HIV infection. Brain Imaging Behav. 2020 ;14(5):2037-2049.
Lipocalin-2 mediates HIV-1 induced neuronal injury and behavioral deficits by overriding CCR5-dependent protection. Brain Behav Immun. 2020 ;89:184-199.
. Low Neuroactive Steroids Identifies a Biological Subtype of Depression in Adults with Human Immunodeficiency Virus on Suppressive Antiretroviral Therapy. J Infect Dis. 2020 .
. Methamphetamine and cardiac disease among people with HIV infection. HIV Med. 2020 ;21(10):635-641.
. Modification of lipid rafts by extracellular vesicles carrying HIV-1 protein Nef induces redistribution of amyloid precursor protein and Tau, causing neuronal dysfunction. J Biol Chem. 2020 ;295(38):13377-13392.
Predictors of worsening neuropathy and neuropathic pain after 12 years in people with HIV. Ann Clin Transl Neurol. 2020 ;7(7):1166-1173.
.